Covered recipient · General Payments record
STEPHANIE LEE MCCARTHY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2023–2024
$476.86
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $223.85 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $72.92 | 3 |
| Acerta Pharma LLC | $55.12 | 3 |
| Alkermes, Inc. | $22.81 | 1 |
| Axsome Therapeutics, Inc. | $20.20 | 1 |
| Amgen Inc. | $18.48 | 1 |
| Otsuka America Pharmaceutical, Inc. | $17.81 | 1 |
| Novo Nordisk AS | $16.51 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.26 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107618860 | CMS |
| ABBVIE INC. | $24.29 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107618862 | CMS |
| ABBVIE INC. | $29.37 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107618864 | CMS |
| Alkermes, Inc. | $22.81 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120550389 | CMS |
| Amgen Inc. | $18.48 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117322532 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.21 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104461296 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.38 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104659523 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.53 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105552738 | CMS |
| Axsome Therapeutics, Inc. | $20.20 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148411882 | CMS |
| Novo Nordisk Inc | $16.51 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100302957 | CMS |
| Otsuka America Pharmaceutical, Inc. | $17.81 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119133212 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.